Revealing the Immunogenic Risk of Polymers

被引:108
作者
Li, Bowen [1 ]
Yuan, Zhefan [2 ]
Hung, Hsiang-Chien [2 ]
Ma, Jinrong [2 ]
Jain, Priyesh [2 ]
Tsao, Caroline [2 ]
Xie, Jingyi [1 ]
Zhang, Peng [2 ]
Lin, Xiaojie [2 ]
Wu, Kan [2 ]
Jiang, Shaoyi [1 ,2 ]
机构
[1] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA
[2] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA
关键词
antibodies; immunochemistry; polymers; protein modifications; zwitterions; ACCELERATED BLOOD CLEARANCE; ANTI-PEG ANTIBODIES; POLYETHYLENE-GLYCOL; ZWITTERIONIC MATERIALS; DRUG-DELIVERY; PROTEINS; BIOPHARMACEUTICALS; PEGYLATION; STRATEGIES; RESISTANCE;
D O I
10.1002/anie.201808615
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Poly(ethylene glycol) (PEG) conjugation has been the gold standard to ameliorate the pharmacokinetic (PK) and immunological profiles of proteins. PEG polymer does become immunogenic once attached to proteins, evoking PEG-specific antibody (Ab) responses. The anti-PEG Abs could cause PEGylated biologic treatments to fail and even result in lethal adverse reactions. Thus the zwitterionic poly(carboxybetaine) (PCB) has been introduced as a PEG substitute for protein modification. Addressed herein is anti-polymer Ab induction by conjugating PEG and PCB polymers to a series of carrier proteins with escalating immunogenicity. Results indicate that titers of PEG-specific Abs were quantitatively correlated to the immunogenicity of carrier proteins, whereas the generation of PCB-specific Abs was minimal and insensitive to increased protein immunogenicity. This work provides insight into the immunological properties of PEG and PCB and has far-reaching implications for the development of polymer-protein conjugates.
引用
收藏
页码:13873 / 13876
页数:4
相关论文
共 39 条
[1]  
[Anonymous], 2018, ANGEW CHEM INT EDIT, DOI [10.1002/ange.201710068, DOI 10.1002/ANGE.201710068]
[2]   Roles of glycine betaine and proline in improving plant abiotic stress resistance [J].
Ashraf, M. ;
Foolad, M. R. .
ENVIRONMENTAL AND EXPERIMENTAL BOTANY, 2007, 59 (02) :206-216
[3]   Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars [J].
Berkowitz, Steven A. ;
Engen, John R. ;
Mazzeo, Jeffrey R. ;
Jones, Graham B. .
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (07) :527-540
[4]   Hydration study of PEG/water mixtures by quasi elastic light scattering, acoustic and rheological measurements [J].
Branca, C ;
Magazù, S ;
Maisano, G ;
Migliardo, F ;
Migliardo, P ;
Romeo, G .
JOURNAL OF PHYSICAL CHEMISTRY B, 2002, 106 (39) :10272-10276
[5]   Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents [J].
Garay, Ricardo P. ;
El-Gewely, Raafat ;
Armstrong, Jonathan K. ;
Garratty, George ;
Richette, Pascal .
EXPERT OPINION ON DRUG DELIVERY, 2012, 9 (11) :1319-1323
[6]   Effect of pegylation on pharmaceuticals [J].
Harris, JM ;
Chess, RB .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (03) :214-221
[7]   Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients [J].
Hershfield, Michael S. ;
Ganson, Nancy J. ;
Kelly, Susan J. ;
Scarlett, Edna L. ;
Jaggers, Denise A. ;
Sundy, John S. .
ARTHRITIS RESEARCH & THERAPY, 2014, 16 (02)
[8]   Anti-polyethyleneglycol Antibody Response to PEGylated Substances [J].
Ishida, Tatsuhiro ;
Kiwada, Hiroshi .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2013, 36 (06) :889-891
[9]   PEGylation of therapeutic proteins [J].
Jevsevar, Simona ;
Kunstelj, Menci ;
Porekar, Vladka Gaberc .
BIOTECHNOLOGY JOURNAL, 2010, 5 (01) :113-128
[10]   Ultralow-Fouling, Functionalizable, and Hydrolyzable Zwitterionic Materials and Their Derivatives for Biological Applications [J].
Jiang, Shaoyi ;
Cao, Zhiqiang .
ADVANCED MATERIALS, 2010, 22 (09) :920-932